Suprachoroidal Injection: A Novel Approach for Targeted Drug Delivery
Treating posterior segment and retinal diseases poses challenges due to the complex structures in the eye that act as robust barriers, limiting medication delivery and bioavailability. This necessitates frequent dosing, typically via eye drops or intravitreal injections, to manage diseases, often le...
Main Authors: | Kevin Y. Wu, Jamie K. Fujioka, Tara Gholamian, Marian Zaharia, Simon D. Tran |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/16/9/1241 |
Similar Items
-
Drug Delivery via the Suprachoroidal Space for the Treatment of Retinal Diseases
by: Liron Naftali Ben Haim, et al.
Published: (2021-06-01) -
A review on polymers in ocular drug delivery systems
by: Amol C. Bisen, et al.
Published: (2024-06-01) -
Mesenchymal Stem Cell-Derived Exosomes in Ophthalmology: A Comprehensive Review
by: Kevin Y. Wu, et al.
Published: (2023-04-01) -
Hyaluronic acid-based nanoparticles to deliver drugs to the ocular posterior segment
by: Hui Jiang, et al.
Published: (2023-12-01) -
Nanocarriers for ocular drug delivery: Recent advances and future opportunities
by: Chetan S Amrutkar, et al.
Published: (2023-01-01)